Cheap Digoxin May Cut Hospitalizations in Heart Failure Patients
UMCG-led studies suggest adding a low-dose digoxin to standard heart failure therapy reduces cardiovascular death risk and HF-related hospitalizations. A broader meta-analysis found a significant ~25% reduction in HF admissions, supporting digoxin’s safety and cost-effectiveness at under ten cents per day. If confirmed, these findings could influence guidelines and broaden access to this inexpensive, centuries-old treatment.